Detalhe da pesquisa
1.
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.
Blood
; 118(6): 1472-80, 2011 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613261